| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
76,148 |
66,817 |
$27.23M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
47,733 |
42,762 |
$10.60M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
329,842 |
287,215 |
$10.15M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,414 |
24,571 |
$4.76M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
61,212 |
50,575 |
$2.55M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
31,527 |
20,443 |
$2.08M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
10,332 |
6,062 |
$1.97M |
| G0378 |
Hospital observation service, per hour |
5,934 |
2,292 |
$1.62M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
32,468 |
27,740 |
$1.49M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,454 |
3,574 |
$1.30M |
| 80053 |
Comprehensive metabolic panel |
161,996 |
130,900 |
$1.18M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,394 |
11,933 |
$959K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14,668 |
11,527 |
$810K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
25,415 |
21,012 |
$757K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
138,199 |
109,928 |
$720K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,851 |
3,314 |
$645K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16,088 |
14,326 |
$639K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,570 |
12,271 |
$635K |
| 36415 |
Collection of venous blood by venipuncture |
305,101 |
236,653 |
$622K |
| 71046 |
Radiologic examination, chest; 2 views |
13,978 |
12,209 |
$595K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,534 |
1,323 |
$588K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
11,216 |
8,355 |
$475K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
525 |
482 |
$420K |
| 71045 |
Radiologic examination, chest; single view |
10,824 |
9,384 |
$408K |
| 87536 |
|
7,554 |
6,609 |
$406K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,487 |
2,890 |
$363K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
14,851 |
4,369 |
$335K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,683 |
1,177 |
$305K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,342 |
9,019 |
$296K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
37,979 |
34,197 |
$279K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15,319 |
9,197 |
$276K |
| 83880 |
|
10,905 |
9,430 |
$267K |
| 31575 |
|
842 |
750 |
$257K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,403 |
5,016 |
$251K |
| 95886 |
|
2,447 |
2,203 |
$242K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,754 |
6,620 |
$241K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,781 |
6,617 |
$240K |
| 80061 |
Lipid panel |
22,507 |
20,552 |
$239K |
| 80050 |
General health panel |
6,442 |
5,734 |
$237K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
5,440 |
4,991 |
$230K |
| 84484 |
|
28,656 |
17,756 |
$225K |
| 95911 |
|
556 |
519 |
$222K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
10,046 |
8,741 |
$218K |
| 86360 |
|
6,825 |
6,056 |
$206K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,782 |
2,500 |
$201K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,346 |
2,194 |
$196K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
3,930 |
3,319 |
$177K |
| 0002A |
|
5,366 |
4,884 |
$171K |
| 73564 |
|
1,756 |
1,433 |
$167K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
742 |
655 |
$165K |
| 86359 |
|
6,935 |
5,951 |
$162K |
| 0001A |
|
5,423 |
5,094 |
$155K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
458 |
429 |
$154K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
951 |
731 |
$144K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
431 |
319 |
$143K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
44 |
36 |
$125K |
| 83970 |
|
3,685 |
3,233 |
$125K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,381 |
8,483 |
$124K |
| 92134 |
|
3,298 |
2,946 |
$115K |
| 95910 |
|
574 |
541 |
$102K |
| 80305 |
|
9,447 |
7,670 |
$101K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
400 |
328 |
$101K |
| 97803 |
|
9,655 |
8,805 |
$98K |
| 81025 |
|
17,310 |
15,331 |
$97K |
| 73610 |
|
1,741 |
1,507 |
$96K |
| 90674 |
|
6,596 |
6,000 |
$96K |
| 87522 |
Neg quan hep c or qual rna |
2,523 |
2,288 |
$95K |
| 95909 |
|
453 |
398 |
$95K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
843 |
673 |
$93K |
| 96417 |
|
1,305 |
806 |
$92K |
| 86780 |
|
8,101 |
7,040 |
$92K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,567 |
4,238 |
$91K |
| 90791 |
Psychiatric diagnostic evaluation |
1,780 |
1,491 |
$91K |
| J9271 |
Injection, pembrolizumab, 1 mg |
15 |
12 |
$91K |
| 84425 |
|
4,907 |
4,308 |
$87K |
| 85027 |
|
15,937 |
14,245 |
$80K |
| 83735 |
|
18,855 |
12,778 |
$79K |
| 92133 |
|
2,052 |
1,883 |
$78K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
872 |
659 |
$73K |
| 82607 |
|
5,823 |
5,160 |
$73K |
| 85610 |
|
27,313 |
21,098 |
$72K |
| 83921 |
|
4,121 |
3,588 |
$71K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
281 |
208 |
$70K |
| 90834 |
Psychotherapy, 45 minutes with patient |
509 |
266 |
$69K |
| 0011A |
|
2,090 |
2,018 |
$68K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
298 |
105 |
$66K |
| 0012A |
|
2,151 |
2,002 |
$66K |
| 73502 |
|
1,013 |
926 |
$66K |
| 82550 |
|
13,942 |
11,811 |
$64K |
| 84207 |
|
4,505 |
3,929 |
$63K |
| 95913 |
|
146 |
138 |
$61K |
| 92083 |
|
2,729 |
2,512 |
$59K |
| 77386 |
|
158 |
13 |
$59K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,433 |
7,524 |
$59K |
| 82746 |
|
4,769 |
4,155 |
$58K |
| 73523 |
|
325 |
298 |
$56K |
| 73130 |
|
1,062 |
825 |
$56K |
| 85730 |
|
14,524 |
12,294 |
$52K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
38 |
24 |
$52K |
| 86803 |
|
4,641 |
4,078 |
$52K |
| 84439 |
|
7,137 |
6,173 |
$51K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
301 |
264 |
$50K |
| 83090 |
|
5,680 |
3,912 |
$50K |
| 84252 |
|
4,550 |
3,976 |
$50K |
| 81001 |
|
22,688 |
19,403 |
$49K |
| 82525 |
|
4,751 |
4,147 |
$49K |
| 86141 |
|
4,333 |
3,789 |
$47K |
| 83605 |
|
5,933 |
4,718 |
$46K |
| 95811 |
|
52 |
49 |
$45K |
| 84630 |
|
4,756 |
4,162 |
$45K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,070 |
1,132 |
$44K |
| 0004A |
|
1,189 |
1,032 |
$44K |
| 86481 |
|
742 |
672 |
$43K |
| 77336 |
|
440 |
180 |
$42K |
| 82390 |
|
4,571 |
3,980 |
$40K |
| 95912 |
|
120 |
107 |
$40K |
| 96523 |
|
1,365 |
991 |
$39K |
| 73562 |
|
803 |
640 |
$37K |
| 84466 |
|
3,766 |
3,243 |
$37K |
| 11721 |
|
1,007 |
917 |
$37K |
| 70498 |
|
110 |
93 |
$36K |
| 31231 |
|
101 |
91 |
$36K |
| 82728 |
|
3,410 |
2,992 |
$36K |
| J1453 |
Injection, fosaprepitant, 1 mg |
356 |
203 |
$34K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
81 |
80 |
$33K |
| 87340 |
|
3,904 |
3,397 |
$32K |
| 91200 |
|
247 |
228 |
$32K |
| 31525 |
|
151 |
135 |
$32K |
| 84600 |
|
2,985 |
2,382 |
$31K |
| 84100 |
|
10,872 |
7,705 |
$31K |
| 96415 |
|
606 |
384 |
$31K |
| 92250 |
|
387 |
374 |
$31K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
294 |
280 |
$30K |
| 93356 |
|
307 |
283 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,726 |
4,004 |
$30K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
500 |
393 |
$29K |
| 72100 |
|
625 |
581 |
$29K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,514 |
1,309 |
$29K |
| 96900 |
|
976 |
231 |
$28K |
| 84481 |
|
2,835 |
2,429 |
$27K |
| 83690 |
|
5,612 |
4,851 |
$27K |
| 20610 |
|
125 |
113 |
$27K |
| 96367 |
|
557 |
368 |
$26K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
3,147 |
2,629 |
$26K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,372 |
2,926 |
$25K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
7,756 |
4,721 |
$25K |
| 0031A |
|
896 |
857 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
324 |
286 |
$24K |
| 73110 |
|
484 |
378 |
$23K |
| 11056 |
|
658 |
575 |
$23K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
824 |
737 |
$23K |
| 73630 |
|
456 |
378 |
$22K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,080 |
917 |
$22K |
| 97802 |
|
1,333 |
1,181 |
$22K |
| 52000 |
|
88 |
79 |
$22K |
| 99215 |
Prolong outpt/office vis |
530 |
461 |
$21K |
| 76536 |
|
183 |
176 |
$20K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
883 |
657 |
$20K |
| 86003 |
|
261 |
187 |
$20K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
78 |
51 |
$20K |
| 29581 |
|
337 |
121 |
$19K |
| 83540 |
|
3,802 |
3,273 |
$18K |
| 97161 |
|
376 |
341 |
$18K |
| 73140 |
|
376 |
304 |
$18K |
| 84134 |
|
3,285 |
2,827 |
$18K |
| 95816 |
|
84 |
79 |
$18K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
10,632 |
9,110 |
$17K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
16 |
12 |
$16K |
| 86706 |
|
1,698 |
1,563 |
$16K |
| 84153 |
|
1,085 |
975 |
$15K |
| 90750 |
|
221 |
208 |
$15K |
| 82962 |
|
6,914 |
4,026 |
$15K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
135 |
114 |
$14K |
| 80375 |
|
1,622 |
1,094 |
$14K |
| 86704 |
|
1,364 |
1,253 |
$14K |
| 97763 |
|
294 |
284 |
$14K |
| 82570 |
|
3,316 |
3,066 |
$13K |
| 80323 |
|
1,502 |
1,006 |
$13K |
| 95908 |
|
89 |
83 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,413 |
2,893 |
$13K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,586 |
2,046 |
$12K |
| 82947 |
|
4,886 |
3,339 |
$12K |
| 80329 |
|
1,118 |
880 |
$12K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
595 |
556 |
$12K |
| 97597 |
|
208 |
169 |
$12K |
| 29580 |
|
275 |
118 |
$12K |
| 86708 |
|
1,111 |
1,021 |
$12K |
| 20611 |
|
52 |
25 |
$11K |
| 81003 |
|
7,796 |
6,534 |
$11K |
| 80074 |
|
378 |
341 |
$11K |
| 81002 |
|
3,592 |
2,598 |
$11K |
| 90837 |
Psychotherapy, 53 minutes with patient |
59 |
26 |
$10K |
| J7050 |
Infusion, normal saline solution, 250 cc |
632 |
393 |
$10K |
| 70496 |
|
32 |
28 |
$10K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
968 |
778 |
$10K |
| 86140 |
|
2,225 |
2,021 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,502 |
2,417 |
$9K |
| 70486 |
|
74 |
64 |
$9K |
| 82043 |
|
2,120 |
1,971 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
890 |
742 |
$9K |
| 92229 |
|
378 |
298 |
$9K |
| 86480 |
|
174 |
159 |
$8K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
18 |
14 |
$8K |
| 64721 |
|
27 |
24 |
$8K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
71 |
62 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13,385 |
9,633 |
$8K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
16 |
14 |
$8K |
| 72110 |
|
96 |
87 |
$8K |
| 90715 |
|
294 |
269 |
$7K |
| 11720 |
|
159 |
150 |
$7K |
| 84480 |
|
1,113 |
991 |
$7K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
105 |
102 |
$7K |
| 86850 |
|
1,589 |
1,347 |
$7K |
| 72040 |
|
160 |
141 |
$6K |
| 85651 |
|
1,851 |
1,689 |
$6K |
| 84681 |
|
4,484 |
2,663 |
$6K |
| 0003A |
|
185 |
153 |
$6K |
| 96411 |
|
76 |
52 |
$6K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
400 |
114 |
$6K |
| 93000 |
|
70 |
67 |
$6K |
| 82105 |
|
485 |
434 |
$6K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,720 |
1,435 |
$6K |
| 77065 |
Tomosynthesis, mammo |
82 |
76 |
$6K |
| 96416 |
|
17 |
13 |
$5K |
| 64615 |
|
27 |
26 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
365 |
295 |
$5K |
| 94726 |
|
30 |
29 |
$5K |
| 72141 |
|
12 |
12 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
171 |
149 |
$5K |
| 90832 |
Psychotherapy, 30 minutes with patient |
93 |
74 |
$5K |
| 86408 |
|
165 |
137 |
$5K |
| 93923 |
|
77 |
74 |
$5K |
| 0054A |
|
124 |
117 |
$4K |
| 90670 |
|
23 |
18 |
$4K |
| 86762 |
|
278 |
233 |
$4K |
| 87210 |
|
921 |
823 |
$4K |
| 96376 |
|
89 |
81 |
$4K |
| 84702 |
|
420 |
372 |
$4K |
| 93350 |
|
13 |
12 |
$4K |
| 0124A |
|
223 |
153 |
$4K |
| 86900 |
|
1,689 |
1,428 |
$4K |
| 90746 |
|
73 |
71 |
$4K |
| 86901 |
|
1,712 |
1,441 |
$4K |
| 77300 |
|
15 |
15 |
$4K |
| 86357 |
|
219 |
196 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
740 |
672 |
$4K |
| 93017 |
|
17 |
16 |
$4K |
| 86160 |
|
257 |
208 |
$4K |
| 97760 |
|
73 |
66 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
173 |
132 |
$3K |
| 90677 |
|
44 |
34 |
$3K |
| 76642 |
|
45 |
37 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,347 |
884 |
$3K |
| 90651 |
|
15 |
14 |
$3K |
| 95885 |
|
30 |
29 |
$3K |
| J9190 |
Injection, fluorouracil, 500 mg |
171 |
48 |
$3K |
| 86235 |
|
61 |
39 |
$3K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
18 |
12 |
$3K |
| 19281 |
|
91 |
51 |
$3K |
| 77073 |
|
25 |
25 |
$3K |
| 83993 |
|
171 |
156 |
$3K |
| 10005 |
|
29 |
13 |
$2K |
| 80320 |
|
816 |
587 |
$2K |
| 80349 |
|
214 |
151 |
$2K |
| 82378 |
|
155 |
119 |
$2K |
| 88112 |
|
107 |
94 |
$2K |
| 80069 |
|
382 |
339 |
$2K |
| 73030 |
|
30 |
26 |
$2K |
| 86355 |
|
131 |
117 |
$2K |
| 72050 |
|
28 |
24 |
$2K |
| 20605 |
|
12 |
12 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
617 |
460 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,586 |
2,016 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,945 |
2,337 |
$2K |
| 81596 |
|
49 |
42 |
$2K |
| 72082 |
|
14 |
13 |
$2K |
| 94729 |
|
30 |
29 |
$2K |
| 87088 |
|
228 |
200 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
17 |
13 |
$2K |
| 80179 |
|
572 |
303 |
$2K |
| 80143 |
|
570 |
302 |
$1K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
46 |
40 |
$1K |
| J1790 |
Injection, droperidol, up to 5 mg |
495 |
388 |
$1K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
29 |
29 |
$1K |
| 0399T |
|
14 |
12 |
$1K |
| 29125 |
|
16 |
16 |
$1K |
| 90734 |
|
14 |
13 |
$1K |
| 73590 |
|
29 |
26 |
$1K |
| 93880 |
|
13 |
12 |
$1K |
| 86225 |
|
126 |
100 |
$1K |
| 90739 |
|
30 |
29 |
$1K |
| 72120 |
|
12 |
12 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
14,953 |
9,237 |
$1K |
| 85007 |
|
596 |
495 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
34 |
26 |
$1K |
| 86593 |
|
327 |
301 |
$1K |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$1K |
| 87077 |
|
136 |
109 |
$1K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
36 |
30 |
$1K |
| 84156 |
|
420 |
372 |
$1K |
| 86703 |
|
103 |
96 |
$953.85 |
| J1644 |
Injection, heparin sodium, per 1000 units |
247 |
164 |
$920.75 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
48 |
27 |
$914.90 |
| 85384 |
|
186 |
165 |
$910.45 |
| 91320 |
|
28 |
26 |
$884.90 |
| 82785 |
|
69 |
61 |
$869.92 |
| 90632 |
|
14 |
13 |
$845.51 |
| 82150 |
|
158 |
139 |
$824.16 |
| 87102 |
|
134 |
123 |
$790.54 |
| 87480 |
|
42 |
33 |
$748.50 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
315 |
226 |
$741.04 |
| 82180 |
|
92 |
84 |
$729.75 |
| 69210 |
|
20 |
19 |
$696.08 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
27 |
12 |
$683.34 |
| 92227 |
|
66 |
59 |
$680.07 |
| 90661 |
|
43 |
39 |
$649.68 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
90 |
86 |
$602.12 |
| 94618 |
|
13 |
12 |
$576.59 |
| 88342 |
|
1,934 |
1,725 |
$575.06 |
| 80353 |
|
52 |
36 |
$570.12 |
| 87660 |
|
39 |
33 |
$561.40 |
| 87510 |
|
39 |
33 |
$561.40 |
| 85660 |
|
109 |
93 |
$560.72 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
261 |
178 |
$557.93 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
25 |
24 |
$540.63 |
| 92285 |
|
12 |
12 |
$510.48 |
| 87206 |
|
135 |
123 |
$506.66 |
| 97165 |
|
14 |
12 |
$506.45 |
| 99152 |
|
869 |
578 |
$491.73 |
| 86787 |
|
49 |
39 |
$486.62 |
| 0051A |
|
17 |
13 |
$466.36 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
208 |
137 |
$463.84 |
| 87186 |
|
46 |
41 |
$433.97 |
| 87516 |
|
13 |
13 |
$428.89 |
| 87081 |
|
28 |
24 |
$421.97 |
| 95249 |
|
15 |
12 |
$420.49 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
133 |
100 |
$416.98 |
| 90686 |
|
16 |
12 |
$388.50 |
| 99153 |
Mod sedat endo service >5yrs |
302 |
201 |
$366.20 |
| C1769 |
Guide wire |
14 |
12 |
$355.23 |
| 83010 |
|
28 |
28 |
$336.96 |
| 84590 |
|
31 |
31 |
$325.08 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
162 |
110 |
$302.22 |
| 86038 |
|
29 |
24 |
$295.11 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
15 |
14 |
$283.63 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
11,412 |
9,802 |
$273.60 |
| 97804 |
|
149 |
144 |
$266.94 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
555 |
375 |
$244.08 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
32 |
25 |
$232.47 |
| 84403 |
|
14 |
13 |
$232.29 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
2,820 |
2,403 |
$230.43 |
| 82565 |
|
42 |
40 |
$205.66 |
| 87040 |
|
12 |
12 |
$196.08 |
| 90656 |
|
197 |
111 |
$195.48 |
| 82977 |
|
28 |
28 |
$194.16 |
| 88173 |
|
23 |
13 |
$179.45 |
| 86705 |
|
15 |
15 |
$164.78 |
| 91300 |
|
13,069 |
9,856 |
$146.55 |
| 83615 |
|
30 |
27 |
$144.96 |
| J2060 |
Injection, lorazepam, 2 mg |
49 |
38 |
$141.99 |
| 83883 |
|
28 |
28 |
$118.32 |
| 90480 |
|
57 |
39 |
$118.32 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
14 |
13 |
$103.30 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
25 |
13 |
$91.80 |
| 90662 |
|
16 |
14 |
$86.52 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,246 |
1,038 |
$75.21 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
159 |
150 |
$56.93 |
| 99443 |
|
40 |
29 |
$54.07 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
183 |
106 |
$48.93 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
17 |
13 |
$47.77 |
| 84550 |
|
16 |
12 |
$45.45 |
| A6258 |
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
159 |
122 |
$41.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
12 |
$40.49 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
17 |
13 |
$36.80 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
21 |
18 |
$34.50 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
31 |
27 |
$30.62 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
1,211 |
1,066 |
$21.67 |
| Q3014 |
Telehealth originating site facility fee |
2,438 |
2,348 |
$16.37 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
25,490 |
14,761 |
$13.78 |
| E0191 |
Heel or elbow protector, each |
123 |
115 |
$12.42 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
91 |
57 |
$11.43 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
118 |
81 |
$8.76 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
14 |
13 |
$4.79 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
71 |
51 |
$0.60 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
47 |
45 |
$0.28 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
208 |
120 |
$0.04 |
| 91312 |
|
308 |
152 |
$0.02 |
| 99001 |
|
14,100 |
8,615 |
$0.00 |
| 82172 |
|
32 |
28 |
$0.00 |
| 88355 |
|
109 |
75 |
$0.00 |
| 90611 |
|
271 |
256 |
$0.00 |
| 99442 |
|
41 |
30 |
$0.00 |
| 80348 |
|
121 |
80 |
$0.00 |
| D1110 |
Prophylaxis - adult |
20 |
13 |
$0.00 |
| 91301 |
|
4,735 |
4,047 |
$0.00 |
| 91303 |
|
942 |
856 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
29 |
24 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
48 |
33 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
65 |
63 |
$0.00 |
| 93289 |
|
15 |
13 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
16 |
14 |
$0.00 |
| 91305 |
|
184 |
172 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
14 |
12 |
$0.00 |
| 99441 |
|
33 |
25 |
$0.00 |